Fibroblast growth factor receptor expression in aural polyps: Predictor of cholesteatoma?

Journal of Laryngology and Otology

Volumn 118, Issue 5, 2004, Pages 338-342

  Nair, Salil ^a   Watts, Simon ^a   Flood, Liam ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cholesteatoma; Cytokines; Ear, Middle; Receptors, Fibroblast Growth Factor

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EAR POLYP; FEMALE; HUMAN; MALE; MUCOSA; POLYP; PREDICTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHOLESTEATOMA, MIDDLE EAR; EAR NEOPLASMS; EAR, MIDDLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYPS; PROTEIN-TYROSINE KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; RETROSPECTIVE STUDIES;

EID: 2942607369     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/002221504323086507     Document Type: Article

References (27)

1. Baumann H, Gauldie J. Acute phase response. Immunol Today 1994;15:74-80
2. Sudhoff H, Bujia J, Holly A, Kim C, Fisseler-Eckhoff A. Functional characterization of middle ear mucosa residues in cholesteatoma samples. Am J Otol 1994;15:217-21
3. Yetiser S, Satar B, Aydin N. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma. Otol Neurotol 2002;23:647-52
4. Ahn JM, Huang CC, Abramson M. Localization of interleukin-1 in human cholesteatoma. Am J Otolaryngol 1990;11:71-7
5. Schilling V, Negri B, Bujia J, Schulz P, Kastenbauer E. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol 1992;13:350-5
6. Milewski C, Fedorowski A, Stan AC, Walter GF. [Basic fibroblast growth factor (b-FGF) in the perimatrix of cholesteatoma]. HNO 1998;46:804-8
7. Milroy CM, Slack RW, Maw AR, Bradfield JW. Aural polyps as predictors of underlying cholesteatoma. J Clin Pathol 1989;42:460-5
8. Veitch D, Brockbank M, Whittet H. Aural polyps and cholesteatoma. Clin Otolaryngol 1988;13:395-7
9. Williams SR, Robinson PJ, Brightwell AP. Management of the inflammatory aural polyp. J Laryngol Otol 1989;103:1040-2
10. Gliklich RE, Cunningham MJ, Eavey RD. The cause of aural polyps in children. Arch Otolaryngol Head Neck Surg 1993;119:669-71
11. Dawes PJ, Soames JV. The inflammatory aural polyp: A predictor of cholesteatoma in children? Austr J Otolaryngol 1995;2:31-3
12. Johnston CL, Cox HC, Gomm JJ, Coombes RC. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J Biol Chem 1995;270:30643-50
13. Tzeng SF, Deibler GE, DeVries GH. Myelin basic protein and myelin basic protein peptides induce the proliferation of Schwann cells via ganglioside GM1 and the FGF receptor. Neurochem Res 1999;24:255-60
14. Joy A, Moffett J, Neary K, Mordechai E, Stachowiak EK, Coons S, et al. Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Oncogene 1997;14:171-83
15. Tay HL, Hussain SS. The management of aural polyps. J Laryngol Otol 1997;111:212-4
16. Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, Baird A, et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 2002;21:793-8
17. Kato A, Ohashi Y, Masamoto T, Sakamoto H, Uekawa M, Nakai Y. Interleukin-6 and tumour necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the eustachian tube. Acta Otolaryngol Suppl 1998;538:90-7
18. Aumente PO, Bujia J, Kim C, Jimenez Gimenez J, Lopez Villarejo P. [A quantitative study of the presence of interleukin-1 and interleukin-6 in cholesteatoma of the middle ear]. Acta Otorrinolaringol Esp 1996;47:259-62
19. Bujia J, Kim C, Holly A, Sudhoff H, Oslos P, Kastenbauer E. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Am J Otol 1996;17:203-6
20. Bujia J, Kim C, Oslos P, Sudhoff H, Kastenbauer E, Hultner L. Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol 1996;253:252-5
21. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992;59:115-65
22. Galzie Z, Kinsella AR, Smith JA. Fibroblast growth factors and their receptors. Biochem Cell Biol 1997;75:669-85
23. Guo L, Degenstein L, Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev 1996;10:165-75
24. Kanai M, Rosenberg I, Podolsky DK. Cytokine regulation of fibroblast growth factor receptor 3 IIIb in intestinal epithelial cells. Am J Physiol 1997;272:G885-93
25. Keresztes M, Boonstra J. Import(ance) of growth factors in(to) the nucleus. J Cell Biol 1999;145:421-4
26. Wiedlocha A, Falnes PO, Rapak A, Munoz R, Klingenberg O, Olsnes S. Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization. Mol Cell Biol 1996;16:270-80
27. Bujia J, Schilling V, Holly A, Stammberger M, Kastenbauer E. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol 1993;113:364-8